DLA Piper advises Point72 Private Investments in Heidi Health Series B financing round

DLA Piper (US) counseled Point72 Private Investments in the US$65 million Series B financing round in Heidi Health, a health technology company that develops artificial intelligence medical scribe software for clinical documentation. 

Charles Torres (New York) led the DLA Piper deal team which included Partners Joel Cox and Nathaniel Law (both Australia), and Associates Taylor Mielnicki and Jasmine Judge (both New York). Additional support provided by Partners Lael Bellamy (Atlanta), Tim Lyons, and Melesa Freerks (both Chicago); Of Counsel Nadia Asancheyev (Washington, DC); and Associate Sarah Birkett (Seattle). 

DLA Piper’s Emerging Growth and Venture Capital practice includes more than 200 lawyers who provide strategic counsel to emerging companies in high-growth industries, including technology, healthcare, pharma and biotech, financial services, manufacturing, and communications. In the last three years, DLA Piper has completed more than 2,100 financings globally totaling more than US$80 billion and is ranked as a top 5 most active US law firm for venture capital deal volume, according to Pitchbook.